Skip to main content
Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery 3/2018

08.10.2018 | Review Article

Transmyocardial revascularization (TMR): current status and future directions

verfasst von: Keith B. Allen, Amy Mahoney, Sanjeev Aggarwal, John Russell Davis, Eric Thompson, Alex F. Pak, Jessica Heimes, A. Michael Borkon

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Sonderheft 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cardiac surgeons are increasingly faced with a more complex patient who has developed a pattern of diffuse coronary artery disease (CAD), which is refractory to medical, percutaneous, and surgical interventions. This paper will review the clinical science surrounding transmyocardial revascularization (TMR) with an emphasis on the results from randomized controlled trials.

Methods

Randomized controlled trials which evaluated TMR used as sole therapy and when combined with coronary artery bypass grafting were reviewed. Pertinent basic science papers exploring TMR’s possible mechanism of action along with future directions, including the synergism between TMR and cell-based therapies were reviewed.

Results

Two laser-based systems have been approved by the United States Food and Drug Administration (FDA) to deliver laser therapy to targeted areas of the left ventricle (LV) that cannot be revascularized using conventional methods: the holmium:yttrium-aluminum-garnet (Ho:YAG) laser system (CryoLife, Inc., Kennesaw, GA) and the carbon dioxide (CO2) Heart Laser System (Novadaq Technologies Inc., (Mississauga, Canada). TMR can be performed either as a stand-alone procedure (sole therapy) or in conjunction with coronary artery bypass graft (CABG) surgery in patients who would be incompletely revascularized by CABG alone. Societal practice guidelines have been established and are supportive of using TMR in the difficult population of patients with diffuse CAD.

Conclusions

Patients with diffuse CAD have increased operative and long-term cardiac risks predicted by incomplete revascularization. The documented operative and long-term benefits associated with sole therapy and adjunctive TMR in randomized trials supports TMR’s increased use in this difficult patient population.
Literatur
1.
Zurück zum Zitat Muhkerjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis – how many patients might be eligible? Am J Cardiol. 1999;84:598–600.CrossRef Muhkerjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis – how many patients might be eligible? Am J Cardiol. 1999;84:598–600.CrossRef
2.
Zurück zum Zitat Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angiogplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol. 1994;73:103–12.CrossRefPubMed Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angiogplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol. 1994;73:103–12.CrossRefPubMed
3.
Zurück zum Zitat Osswald BR, Blackstone EH, Tochtermann U, et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur J Cardiothorac Surg. 2001;20:120–6.CrossRefPubMed Osswald BR, Blackstone EH, Tochtermann U, et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur J Cardiothorac Surg. 2001;20:120–6.CrossRefPubMed
4.
Zurück zum Zitat Mohr FW, Rastan AJ, Serruys PW, et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg. 2011;141:130–40.CrossRefPubMed Mohr FW, Rastan AJ, Serruys PW, et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg. 2011;141:130–40.CrossRefPubMed
5.
Zurück zum Zitat Allen KB. Holmium:YAG laser system for transmyocardial revascularization. Expert Rev Med Devices. 2006;3:137–46.CrossRefPubMed Allen KB. Holmium:YAG laser system for transmyocardial revascularization. Expert Rev Med Devices. 2006;3:137–46.CrossRefPubMed
6.
Zurück zum Zitat Schaff H, Gersh BJ, Pluth J, et al. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation. 1983;68:II200–4. Schaff H, Gersh BJ, Pluth J, et al. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation. 1983;68:II200–4.
7.
Zurück zum Zitat Lawrie GM, Morris GC, Silvers A, et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation. 1982;66:717–23.CrossRefPubMed Lawrie GM, Morris GC, Silvers A, et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation. 1982;66:717–23.CrossRefPubMed
8.
Zurück zum Zitat Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery (CASS) Registery. Circulation. 1992;86:446–57.CrossRefPubMed Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery (CASS) Registery. Circulation. 1992;86:446–57.CrossRefPubMed
9.
Zurück zum Zitat Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–9. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–9.
10.
Zurück zum Zitat Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009;361:235–44. Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009;361:235–44.
11.
Zurück zum Zitat Allen KB, Dowling RD, Heimansohn DA, Reitsma E, Didelot G, Shaar CJ. Transmyocardial revascularization utilizing a holmium:YAG laser. Eur J Cardiothorac Surg. 1998;14:S100–4.CrossRefPubMed Allen KB, Dowling RD, Heimansohn DA, Reitsma E, Didelot G, Shaar CJ. Transmyocardial revascularization utilizing a holmium:YAG laser. Eur J Cardiothorac Surg. 1998;14:S100–4.CrossRefPubMed
12.
Zurück zum Zitat Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–36.CrossRefPubMed Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–36.CrossRefPubMed
13.
Zurück zum Zitat Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–8.CrossRefPubMed Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–8.CrossRefPubMed
14.
Zurück zum Zitat Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet. 1999;354:885–90.CrossRefPubMed Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet. 1999;354:885–90.CrossRefPubMed
15.
Zurück zum Zitat Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519–24.CrossRefPubMed Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519–24.CrossRefPubMed
16.
Zurück zum Zitat Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascualrization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170–7.CrossRefPubMed Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascualrization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170–7.CrossRefPubMed
17.
Zurück zum Zitat Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascularization: five-year follow-up of a prospective, randomized, multicenter trial. Ann Thorac Surg. 2004;77:1228–34.CrossRefPubMed Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascularization: five-year follow-up of a prospective, randomized, multicenter trial. Ann Thorac Surg. 2004;77:1228–34.CrossRefPubMed
18.
Zurück zum Zitat Horvath KA, Aranki SF, Cohn LH, et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO2 laser. Circulation. 2001;104:I-81–4.CrossRef Horvath KA, Aranki SF, Cohn LH, et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO2 laser. Circulation. 2001;104:I-81–4.CrossRef
19.
Zurück zum Zitat Cheng D, Diegeler A, Allen K, et al. Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials. Innovations. 2006;1:295–313.CrossRefPubMed Cheng D, Diegeler A, Allen K, et al. Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials. Innovations. 2006;1:295–313.CrossRefPubMed
20.
Zurück zum Zitat Myers J, Oesterle S, Jones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J. 2002;143:1052–7.CrossRefPubMed Myers J, Oesterle S, Jones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J. 2002;143:1052–7.CrossRefPubMed
21.
Zurück zum Zitat Bridges CR, Horvath KA, Nugent B, Shahian DM, Haan CK, Shemin RJ. Society of Thoracic Surgeons practice guideline: transmyocardial laser revascularization. Ann Thorac Surg. 2004;77:1484–502.CrossRef Bridges CR, Horvath KA, Nugent B, Shahian DM, Haan CK, Shemin RJ. Society of Thoracic Surgeons practice guideline: transmyocardial laser revascularization. Ann Thorac Surg. 2004;77:1484–502.CrossRef
22.
Zurück zum Zitat Diegeler A, Cheng D, Allen K, et al. Transmyocardial laser revascularization: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2006. Innovations. 2006;1:314–22.CrossRefPubMed Diegeler A, Cheng D, Allen K, et al. Transmyocardial laser revascularization: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2006. Innovations. 2006;1:314–22.CrossRefPubMed
23.
Zurück zum Zitat Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation. 2003;107:149–58.CrossRefPubMed Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation. 2003;107:149–58.CrossRefPubMed
24.
Zurück zum Zitat Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:3097–137.CrossRefPubMed Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:3097–137.CrossRefPubMed
25.
Zurück zum Zitat Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2610–42.CrossRefPubMed Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2610–42.CrossRefPubMed
26.
Zurück zum Zitat Wehberg KE, Julian JS, Todd JC, Ogburn N, Klopp E, Buchness M. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg Forum. 2003;6:328–30.PubMed Wehberg KE, Julian JS, Todd JC, Ogburn N, Klopp E, Buchness M. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg Forum. 2003;6:328–30.PubMed
27.
Zurück zum Zitat Peterson ED, Kaul P, Kaczmarek RG, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2003;42:1611–6.CrossRefPubMed Peterson ED, Kaul P, Kaczmarek RG, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2003;42:1611–6.CrossRefPubMed
28.
Zurück zum Zitat Allen KB, Dowling RD, Richenbacher W. From controlled trial to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2004;43:2364–5.CrossRefPubMed Allen KB, Dowling RD, Richenbacher W. From controlled trial to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2004;43:2364–5.CrossRefPubMed
29.
Zurück zum Zitat Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–9. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540–9.
30.
Zurück zum Zitat Allen KB, Dowling RD, Schuch DR, et al. Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized, trial. Ann Thorac Surg. 2004;78:458–65.CrossRefPubMed Allen KB, Dowling RD, Schuch DR, et al. Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized, trial. Ann Thorac Surg. 2004;78:458–65.CrossRefPubMed
31.
Zurück zum Zitat Frazier OH, Boyce SW, Griffith BP, et al. Transmyocardial revascularization using a synchronized CO2 laser as adjunct to coronary artery bypass grafting: results of a prospective, randomized multi-center trial with 12 month follow-up. Circulation. 1999:100:I248. Frazier OH, Boyce SW, Griffith BP, et al. Transmyocardial revascularization using a synchronized CO2 laser as adjunct to coronary artery bypass grafting: results of a prospective, randomized multi-center trial with 12 month follow-up. Circulation. 1999:100:I248.
32.
Zurück zum Zitat Frazier OH, Tuzun E, Eichstadt A, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Tex Heart J. 2004;31:231–9. Frazier OH, Tuzun E, Eichstadt A, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Tex Heart J. 2004;31:231–9.
33.
Zurück zum Zitat Diamond EG, Kittle CF, Crockett JE. Evaluation of internal mammary artery ligation and sham procedure in angina pectoris. Circulation. 1958;18:712–3. Diamond EG, Kittle CF, Crockett JE. Evaluation of internal mammary artery ligation and sham procedure in angina pectoris. Circulation. 1958;18:712–3.
34.
Zurück zum Zitat Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal- mammary- artery ligation by a double-blind technic. N Engl J Med. 1959;260:1115–8.CrossRefPubMed Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal- mammary- artery ligation by a double-blind technic. N Engl J Med. 1959;260:1115–8.CrossRefPubMed
35.
Zurück zum Zitat Kwong KF, Kanellopoulos GK, Nickols JC, et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883–90.CrossRefPubMed Kwong KF, Kanellopoulos GK, Nickols JC, et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883–90.CrossRefPubMed
36.
Zurück zum Zitat Al-Sheikh T, Allen KB, Straka SP, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999;100:135–40.CrossRefPubMed Al-Sheikh T, Allen KB, Straka SP, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999;100:135–40.CrossRefPubMed
37.
Zurück zum Zitat Beek JF, van der Sloot JA, Huikeshoven M, et al. Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. J Thorac Cardiovasc Surg. 2004;127:517–24.CrossRefPubMed Beek JF, van der Sloot JA, Huikeshoven M, et al. Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. J Thorac Cardiovasc Surg. 2004;127:517–24.CrossRefPubMed
38.
Zurück zum Zitat Muxi A, Magrina J, Martin F, et al. Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanide scintigraphy in the assessment of transmyocardial laser revascularization. J Thorac Cardiovasc Surg. 2003;125:1493–8.CrossRefPubMed Muxi A, Magrina J, Martin F, et al. Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanide scintigraphy in the assessment of transmyocardial laser revascularization. J Thorac Cardiovasc Surg. 2003;125:1493–8.CrossRefPubMed
39.
Zurück zum Zitat Hughes GC, Baklanov DV, Biswas SS, et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. J Card Surg. 2004;19:21–7.CrossRefPubMed Hughes GC, Baklanov DV, Biswas SS, et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. J Card Surg. 2004;19:21–7.CrossRefPubMed
40.
Zurück zum Zitat Tran R, Brazio PS, Kallam S, Gu J, Poston RS. Transmyocardial laser revascularization enhances blood flow within bypass grafts. Innovations. 2007;2:226–30.CrossRefPubMed Tran R, Brazio PS, Kallam S, Gu J, Poston RS. Transmyocardial laser revascularization enhances blood flow within bypass grafts. Innovations. 2007;2:226–30.CrossRefPubMed
41.
Zurück zum Zitat Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization.JACC.1998;31:1426–33. Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization.JACC.1998;31:1426–33.
42.
Zurück zum Zitat Kohmoto T, DeRosa CM, Yamamoto N, et al. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360–7.CrossRefPubMed Kohmoto T, DeRosa CM, Yamamoto N, et al. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360–7.CrossRefPubMed
43.
Zurück zum Zitat Malekan R, Reynolds CF, Narula N, Kelley ST, Suzuki Y, Bridges CR. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation. 1998;98:II62–5.PubMed Malekan R, Reynolds CF, Narula N, Kelley ST, Suzuki Y, Bridges CR. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation. 1998;98:II62–5.PubMed
44.
Zurück zum Zitat Huikeshoven M, Belien J, Tukkie R, Beek JF. The vascular response induced by transmyocardial laser revascularization is determined by the size of the channel scar: results of CO2, holmium and excimer lasers. Lasers Surg Med. 2004;35:35–40.CrossRefPubMed Huikeshoven M, Belien J, Tukkie R, Beek JF. The vascular response induced by transmyocardial laser revascularization is determined by the size of the channel scar: results of CO2, holmium and excimer lasers. Lasers Surg Med. 2004;35:35–40.CrossRefPubMed
45.
Zurück zum Zitat Hughes GC, Lowe JE, Kypson AP, et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg. 1998;66:2029–36.CrossRefPubMed Hughes GC, Lowe JE, Kypson AP, et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg. 1998;66:2029–36.CrossRefPubMed
46.
Zurück zum Zitat Hughes GC, Kypson AP, Annex BH, et al. Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers. Ann Thorac Surg. 2000;70:504–9.CrossRefPubMed Hughes GC, Kypson AP, Annex BH, et al. Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers. Ann Thorac Surg. 2000;70:504–9.CrossRefPubMed
47.
Zurück zum Zitat Hughes GC, Biswas SS, Yin B, et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol2002;39:1220–28.CrossRefPubMed Hughes GC, Biswas SS, Yin B, et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol2002;39:1220–28.CrossRefPubMed
48.
Zurück zum Zitat Domkowski PW, Biswas SS, Steenbergen C, Lowe JE. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation. 2001;103:469–71.CrossRefPubMed Domkowski PW, Biswas SS, Steenbergen C, Lowe JE. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation. 2001;103:469–71.CrossRefPubMed
49.
Zurück zum Zitat Hughes GC, Lowe JE. Revascularization versus denervation: what are the mechanisms of symptom relief? In: Abela GS, editor. Myocardial revascularization: novel percutaneous approaches. New York: Wiley-Liss; 2002. p. 63–79. Hughes GC, Lowe JE. Revascularization versus denervation: what are the mechanisms of symptom relief? In: Abela GS, editor. Myocardial revascularization: novel percutaneous approaches. New York: Wiley-Liss; 2002. p. 63–79.
50.
Zurück zum Zitat Allen KB, Kelly J, Borkon AM, et al. TMR: from randomized trials to clinical practice. a review of techniques, evidence based outcomes, and future directions. Anesthesiol Clin. 2008;26:501–19.CrossRefPubMed Allen KB, Kelly J, Borkon AM, et al. TMR: from randomized trials to clinical practice. a review of techniques, evidence based outcomes, and future directions. Anesthesiol Clin. 2008;26:501–19.CrossRefPubMed
51.
Zurück zum Zitat Atluri P, Suarez EE, Liao GP, et al. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J Thorac Cardiovasc Surg. 2008;135:283–91.CrossRefPubMed Atluri P, Suarez EE, Liao GP, et al. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J Thorac Cardiovasc Surg. 2008;135:283–91.CrossRefPubMed
52.
Zurück zum Zitat Horvath KA, Chiu E, Maun D, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg. 1999;68:825–9.CrossRefPubMed Horvath KA, Chiu E, Maun D, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg. 1999;68:825–9.CrossRefPubMed
53.
Zurück zum Zitat Selke FW, Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg. 2003;75:S685–90.CrossRef Selke FW, Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg. 2003;75:S685–90.CrossRef
54.
Zurück zum Zitat Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165–72.CrossRefPubMed Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165–72.CrossRefPubMed
55.
Zurück zum Zitat Pompillo G, Steinhoff G, Liebold A, et al. Direct minimally invasive intramyocardial injection of bone marrow -derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg. 2008;56:71–6.CrossRef Pompillo G, Steinhoff G, Liebold A, et al. Direct minimally invasive intramyocardial injection of bone marrow -derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg. 2008;56:71–6.CrossRef
56.
Zurück zum Zitat Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–5.CrossRefPubMed Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–5.CrossRefPubMed
57.
Zurück zum Zitat Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989–97.CrossRefPubMed Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989–97.CrossRefPubMed
58.
Zurück zum Zitat Patel AN, Spadaccio C, Kuzman M, et al. Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplant. 2007;16:899–905.CrossRefPubMed Patel AN, Spadaccio C, Kuzman M, et al. Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplant. 2007;16:899–905.CrossRefPubMed
59.
Zurück zum Zitat Rosenzweig A. Cardiac cell therapy – mixed results from mixed cells. N Engl J Med. 2006;355:1274–7.CrossRefPubMed Rosenzweig A. Cardiac cell therapy – mixed results from mixed cells. N Engl J Med. 2006;355:1274–7.CrossRefPubMed
60.
Zurück zum Zitat Reyes G, Allen KB, Aguado B, et al. Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease. Eur J Cardiothorac Surg. 2009;36:192–4.CrossRefPubMed Reyes G, Allen KB, Aguado B, et al. Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease. Eur J Cardiothorac Surg. 2009;36:192–4.CrossRefPubMed
Metadaten
Titel
Transmyocardial revascularization (TMR): current status and future directions
verfasst von
Keith B. Allen
Amy Mahoney
Sanjeev Aggarwal
John Russell Davis
Eric Thompson
Alex F. Pak
Jessica Heimes
A. Michael Borkon
Publikationsdatum
08.10.2018
Verlag
Springer Singapore
Erschienen in
Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe Sonderheft 3/2018
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-018-0702-7

Weitere Artikel der Sonderheft 3/2018

Indian Journal of Thoracic and Cardiovascular Surgery 3/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.